Abstract
Infusion phlebitis is a common clinical problem that is observed with some antimicrobial agents, when being administered intravenously. In this study, cultured murine fibroblasts and immortalised human endothelial cells were exposed to three antibiotics at clinically relevant concentrations to assess their toxic potential in two established cytotoxicity assays. BALB/c 3T3 fibroblasts and Eahy926 endothelial cells were exposed to quinupristin/dalfopristin (QD), erythromycin and levofloxacin at increasing concentrations. For assessment of cytotoxicity the cells were incubated with neutral red (NR) or stained with crystal violet (CV). Measurements were done by photometry. At the concentration range tested QD and erythromycin showed a concentration-dependent cytotoxic effect in both cell cultures. In 3T3 cells the half-maximal effect concentration (EC50) was 20 mg/l for QD and 340 mg/l for erythromycin in the NR uptake test and 12 and 200 mg/l, respectively, in the CV assay. In Eahy926 cells the EC50 was 50 mg/l for QD and 880 mg/l for erythromycin in the NR uptake test and 40 and 750 mg/l, respectively, in the CV assay. No EC50 could be established in both cell types for levofloxacin. Eahy926 cells were less sensitive to cytotoxic stimuli than 3T3 fibroblasts. Cytotoxic effects in both cell cultures occurred in the following order: QD > erythromycin >> levofloxacin. This ranking correlates well with the frequency of local adverse effects observed with the infusion of these antibiotics in patients. Thus, these in vitro assays may serve as an estimate for the prediction of local tolerability of antibiotics when administered parenterally.
Similar content being viewed by others
References
Armbruster C, Robibaro B, Griesmacher A, Vorbach H (2000) Endothelial cell compatibility of trovafloxacin and levofloxacin for intravenous use. J Antimicrob Chemother 45:533–535
Bergeron MG, Trottier S, Lepage MC, Chevalier P, Geary B, Montay G, Rey J (1997) A phase I, open-label, single-dose study of blood and blister fluid pharmacokinetics of quinupristin/dalfopristin (Q/D, RP59500, Synercid). In: proceeding of the 37th interscience conference on antimicrobial agents and chemotherapy (ICAAC), Toronto, Canada 28 9–1 10 97; AB:A–117
Borenfreund E, Puerner JA (1985) Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24:119–124
Curran ET, Coia JE, Gilmour H, McNamee S, Hood J (2000) Multi-centre research surveillance project to reduce infections/phlebitis associated with peripheral vascular catheters. J Hosp Infect 46:194–202
De Dios Garcia-Diaz J, Santolaya Perrin R, Paz Martinez Ortega M, Moreno-Vazquez M (2001) Phlebitis due to intravenous administration of macrolide antibiotics. A comparative study of erythromycin versus clarithromycin. Med Clin (Barc) 116:133–135
File TM Jr, Segreti J, Dunbar L, Player R, Kohler R, Williams RR, Kojak C, Rubin A (1997) A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob Agents Chemother 41:1965–1972
Flick DA, Gifford GE (1984) Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 68:167–175
Gaukroger PB, Roberts JG, Manners TA (1988) Infusion thrombophlebitis: a prospective comparison of 645 Vialon and Teflon cannulae in anaesthetic and postoperative use. Anaesth Intensive Care 16:265–271
Homer LD, Holmes KR (1998) Risks associated with 72- and 96-hour peripheral intravenous catheter dwell times. J Intraven Nurs 21:301–305
Karadag A, Gorgulu S (2000) Effect of two different short peripheral catheter materials on phlebitis development. J Intraven Nurs 23:158–66
Kilic B, Kruse M, Stahlmann R (2006) The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926). Toxicology 218:30–38
Kuwahara T, Asanami S, Kubo S (1998) Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. Nutrition 14:496–501
Lanbeck P, Paulsen O (1995) Cytotoxic effects of four antibiotics on endothelial cells. Pharmacol Toxicol 77:365–370
Lanbeck P, Paulsen O (2001) Short-term effects of four antibiotics on DNA synthesis in endothelial cells. Pharmacol Toxicol 88:204–208
Lanbeck P, Odenholt I, Paulsen O (2002) Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study. Scand J Infect Dis 34:512–519
Lanbeck P, Odenholt I, Riesbeck K (2004) Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis. J Antimicrob Chemother 53:174–179
Lewis GB, Hecker JF (1985) Infusion thrombophlebitis. Br J Anaesth 57:220–233
Lubasch A, Keller I, Borner K, Koeppe P, Lode H (2000) Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers. Antimicrob Agents Chemother 44:2600–2603
Maki DG, Ringer M (1991) Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann Intern Med 114:845–854
Monreal M, Quilez F, Rey-Joly C, Rodriguez S, Sopena N, Neira C, Roca J (1999) Infusion phlebitis in patients with acute pneumonia: a prospective study. Chest 115:1576–1580
Neaverson MA (1976) Intravenous administration of erythromycin: serum, sputum and urine levels. Curr Med Res Opin 4:359–364
Oberle S, Schroder H (1997) Ferritin may mediate SIN-1-induced protection against oxidative stress. Nitric Oxide 1:308–314
Parsons RL, David JA, Raymond K, Stamp SM (1980) Pharmacokinetics of intravenous erythromycin lactobionate. J Int Med Res 8(Suppl 2):15–23
Rubinstein E, Prokocimer P, Talbot GH (1999) Safety and tolerability of quinupristin/dalfopristin: administration guidelines. J Antimicrob Chemother 44(Suppl A):37–46
Schleger C, Platz SJ, Deschl U (2004) Development of an in vitro model for vascular injury with human endothelial cells. ALTEX 21:12–19
Seki Y, Toba K, Fuse I, Sato N, Niwano H, Takahashi H, Tanabe N, Aizawa Y (2005) In vitro effect of cyclosporin A, mitomycin C and prednisolone on cell kinetics in cultured human umbilical vein endothelial cells. Thromb Res115:219–228
Stahlmann R (2000) Veträglichkeit von Quinupristin-Dalfopristin. Chemother J 9:86–89
Zimmermann T, Laufen H, Riedel K-D, Treadway G, et al (2001) Comperative tolerability of intravenous azithromycin, clarithromycin and erythromycin in healthy volunteers. Clin Drug Invest 21:527–536
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kruse, M., Kilic, B., Flick, B. et al. Effect of quinupristin/dalfopristin on 3T3 and Eahy926 cells in vitro in comparison to other antimicrobial agents with the potential to induce infusion phlebitis. Arch Toxicol 81, 447–452 (2007). https://doi.org/10.1007/s00204-006-0163-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-006-0163-4